Was nice to see those shares finally get bought.
Fully diluted the company's worth approx. .33 pps, right where insiders own the controlling preferred. So anything picked up down here is like getting in where insiders did in my opinion. But also keep in mind, there is no debt, sales are way up Qtr over Qtr, and currently common are worth just under $2 pps while the preferred stay intact.
They did update their company profile and s/s on the otcmarket's website on the last business day of the quarter, like clockwork.
I tried getting ahold of the CFO but she's out if the office until next week. I'll post my questions and answers here when she gets back.
She did tell me to pass the word to anyone with questions to reach out to her last time we talked.
Short term outlook, lots of patience needed but worth the wait. They apparently won't release fluff news, which is great in my opinion.
Long term, I believe we are closer to a big board style PR campaign everyday. Every quarter the numbers are improving, I don't expect anything less for Q2 that just ended. Once they have their numbers looking their sharpest, we should get the news we've longed for.
